Parliament Workbench
Data: Official Report to 12 Nov 2026

Official Report · Committee

Continued Petitions

Tick-borne Diseases (Treatment) (PE1662)

Wednesday 24 February 2021 Public Petitions Committee About 09:30–10:15 Petitions 58 contributions · 10 speakers

Speakers

Choose an MSP to read only their contributions

The record

58 contributions
Gail Ross SNP The Deputy Convener · Caithness, Sutherland and Ross
link

The second item on our agenda is consideration of continued petitions. The first continued petition, PE1662, which was lodged by Janey Cringean and Lorraine Murray on behalf of Tick-borne Illness Campaign Scotland, calls on the Scottish Parliament to

“urge the Scottish Government to improve testing and treatment for Lyme Disease and associated tick-borne diseases by ensuring that medical professionals in Scotland are fully equipped to deal with the complexity of tick-borne infections, addressing the lack of reliability of tests, the full variety of species in Scotland, the presence of ‘persister’ bacteria which are difficult to eradicate, and the complexities caused by the presence of possibly multiple co-infections, and to complement this with a public awareness campaign.”

I welcome Alexander Burnett MSP, who is joining us for this item.

At our previous consideration of the petition, in December 2020, we agreed to invite the then Minister for Public Health, Sport and Wellbeing and the chief medical officer to give oral evidence. I am pleased to welcome Mairi Gougeon, the Minister for Public Health and Sport; in place of the CMO, Dr Gill Hawkins, who is the Scottish Government’s senior medical officer for health protection; and Professor Tom Evans, who is the CMO specialty adviser on infectious diseases. Thank you all for joining us. I invite the minister to provide a brief opening statement before we move to questions.

Mairi Gougeon SNP The Minister for Public Health and Sport · Angus North and Mearns
link

I am pleased to be in front of the committee today, because it is right that Lyme disease is taken seriously and receives this kind of scrutiny. For some people, Lyme disease has lasting and life-altering impacts, which is why it is so important that we get diagnosis, testing and treatment right. I am by no means an expert on this, but I know that no one organisation or clinician has all the answers. It will be—we hope—through collaboration and robust evidence gathering and analysis that answers are found. I very much appreciate the role that the committee is playing in that process.

The Scottish Government and its public health partners are committed to supporting people with Lyme disease, finding new and better diagnostic and treatment tools, and trying to prevent it in the first place. None of those tasks is easy and I fully understand the frustration of people who feel that progress is too slow or that not enough is being done. However, I assure the committee that we have world-class lab facilities in Scotland, which often work with international partners to ensure that testing is robust and meets the highest standards. We have a network of public health experts who are dedicated to ensuring that health professionals are aware of the symptoms of Lyme disease and understand how best to support patients who have or are suspected of having it.

As in many other areas, the pandemic has had a huge impact on how much we can progress work on these matters, which I appreciate adds more frustration to the situation. However, we will do all that we can within current constraints, and we will do more when pressures ease. Last week, I met the petitioners to emphasise those points and reassure them about that.

I highlight a round-table event that we will hold in the coming weeks, bringing together clinicians, patient representatives and public health experts to discuss the matter further. In keeping with the idea of collaboration and analysis that I mentioned earlier, the event comes on the back of the petitioners suggesting it, and I am grateful to them for doing so. I am very hopeful that it will inform what we do next.

As I said, I am not an expert in the field, but I am guided by the advice of those who are. I look forward to committee members’ questions. Where clinical and public health expertise is needed to provide more clarity on any responses, my colleagues, Gill Hawkins and Tom Evans, are here with me. They, too, will be happy to answer questions.

Gail Ross SNP The Deputy Convener · Caithness, Sutherland and Ross
link

Thank you, minister. That is positive news.

I will start off by asking about Dr Cruikshank’s submission. She states:

“10-20% of Lyme disease infections result in persistent symptoms”.

She also states:

“Clinicians frequently report a limited understanding of the disease whilst still insisting that ‘Chronic Lyme disease does not exist’.”

It appears that there is a risk of patients being denied not only national health service treatment, but compassion from clinicians, some of whom outwardly dismiss concerns. Does NHS Scotland acknowledge the existence of persistent or chronic Lyme disease?

Mairi Gougeon SNP Angus North and Mearns
link

When I met Dr Cringean last week, her point about patients’ concerns being dismissed really came across. I emphasise that we do not want patients’ concerns to be dismissed by anyone; no one should be left feeling as though that is how they have been treated.

My clinical colleagues are probably better placed to respond to your specific point. However, I assure the committee that the Government is firmly committed to ensuring that, as far as is possible, patients who are ill get the appropriate treatment to help them to recover and that, if the cause of their symptoms is unclear, we do all that we can to get to the bottom of that. Perhaps Tom Evans will elaborate further on that point.

Professor Tom Evans Scottish Government
link

I have worked in the infectious disease field in Scotland for just over 17 years and I have probably seen and treated hundreds of patients with Lyme disease. I am well aware of the problems that the petitioners outline.

There are two issues. First, what do we know about patients who present with persistent symptoms and how common is that? Secondly, are clinicians aware of that and what are they doing about it? The evidence is that there are not many people with persistent symptoms, which I always preface by noting that that does not mean that I do not care or do not want to be sympathetic or empathetic. Unfortunately, there has been a breakdown of communication between doctors and patients in that area, which is hugely regrettable. As the minister said, we all want to help people—that is what we are in it for—and to give them the best help that we can.

The symptoms are common in the general population, which is where complications can arise. Population surveys have looked at a variety of symptoms that patients have said that they suffer from after having Lyme disease, but the symptoms turn out to be quite common in people who do not have it, so it is difficult to get an accurate representation. For example, a study in Slovenia in eastern Europe, where there is a lot of Lyme disease, followed nearly 300 patients after they had had Lyme disease, as well as a carefully matched group of controls. Only about 2 per cent of patients in each group had such symptoms after 12 months. Patients suffering persistent symptoms is certainly a problem—I do not deny that—but it is not as big a problem as the figures that you cited suggest.

The issue of awareness and public understanding of the disease is important; we have common ground with the petitioners on that. My opinion is that more could be done in that area, particularly with primary care physicians, some of whom have excellent knowledge of the disease and some of whom are not well acquainted with it. The same is true in secondary care. We have some initiatives that I hope will improve that, which we might come on to later. Perhaps my colleague, Dr Gill Hawkins, who works in public health, will address that point.

Dr Gill Hawkins Scottish Government
link

There is certainly variation in healthcare practitioners’ degree of knowledge about Lyme. In certain areas of Scotland where it is more prevalent and general practitioners see more of it, they are more confident in recognising, diagnosing and treating it.

There is work that we can do to improve the awareness of our clinical colleagues, from our pharmacies to our GPs and secondary care colleagues. Some work on Lyme disease has already been undertaken by the Scottish health protection network. We hope to build on that and create even more awareness-raising opportunities to continue to get the message across.

Early recognition, early treatment and thinking about Lyme disease are key. People know a lot about the Lyme rash, or target rash, which we see, but it is important to raise awareness about other symptoms and more unusual presentations that GPs who do not have much experience of Lyme are more likely to miss. There is certainly work that we can do to improve recognition and diagnosis in the early stages when we can treat Lyme. That is my main point on where we can go with awareness raising.

Gail Ross SNP The Deputy Convener · Caithness, Sutherland and Ross
link

Minister, the petitioners state that chronic Lyme patients who pay for private treatment often recover, but the treatments are not available on the NHS. Why is that the case?

Mairi Gougeon SNP Angus North and Mearns
link

That question would be more appropriate for my clinical colleagues. It is not my place to comment on treatments and I would not be able to comment on treatments that are available privately. The NHS would support patients to manage symptoms that they are experiencing. I hope that since the petitioners first developed their symptoms the approach will have improved. I will bring in Tom Evans.

Professor Evans
link

There are two issues. First, we want to be sure that use of any treatment that we offer in the NHS is evidence-based and will do patients some good. That is not the case just for Lyme disease, but for any condition. Clinicians rely on international experience and evidence. We have the benefit of the National Institute for Health and Care Excellence, which is United Kingdom based, but there is also the European Centre for Disease Prevention and Control and the Centers for Disease Control and Prevention in North America, where Lyme disease was first recognised and there is a huge amount of Lyme disease.

There is a large body of international evidence on treatments and what best can be done for patients who are suffering. In particular, longer-term antibiotic treatment has been looked at. Very commonly, patients with Lyme disease ask me whether it will do them any good to have antibiotics for a month or two, or six months. The evidence is that it would not. There have been a number of large trials including blind comparison of patients who had antibiotics with patients who had a placebo, so we did not know which group was which. The overwhelming evidence in those trials is that the longer-term antibiotics did not offer anything better than the placebo. Both groups showed improvement, but there was no difference based on whether the patients had had antibiotics. Certainly, from my perspective and those of my clinicians, that treatment is not justified based on the available evidence.

That is not to say that there will not be evidence in the future to support such treatment; we always keep an open mind. We would not give patients longer-term antibiotics based on the current available evidence. I have seen one of my patients who received longer-term antibiotics having a serious reaction to them, so they are not entirely risk-free. We have to make sure that we strike the right balance between risk and harm.

There is definitely room for improvement in what treatment we offer to people who have longer-term symptoms and who are clearly suffering. We are lacking evidence on that. NICE, the European Centre for Disease Prevention and Control and the Infectious Diseases Society of America guidelines all acknowledge that that is an area in which more research is needed.

That shades into other areas such as chronic fatigue syndrome and, of course, as we have seen recently, patients who are experiencing longer-term symptoms after Covid. Whether those have similar underlying causes and whether treatments will work for all groups and so on, we do not honestly know, so we need better evidence to see how best we can help those people.

Antibiotics and some other treatments that are offered privately are not, to the best of my knowledge, based on evidence, treatments that we can recommend currently. I hope that helps and sets out what we can do and perhaps what we need to know. Perhaps Gill Hawkins wants to add something from the public health perspective.

09:45

Dr Hawkins
link

The views that Professor Evans has expressed are in keeping with those of the clinical experts who have been advising the Scottish health protection network about education, awareness-raising and clinical aspects of the treatment of Lyme disease.

Awareness is needed among the clinical profession about people who have longer-term symptoms and who need support and management of those symptoms. There might be a debate about antibiotics, but there is no debate about the need to provide holistic care to people who have long-term symptoms, by making sure that the symptoms are being addressed and taken seriously, and that the people feel that they are being supported. We hope that awareness-raising will improve the patient experience for those who unfortunately suffer from the longer-term symptoms.

Maurice Corry Con West Scotland
link

Chronic Lyme disease is a multisystem infection, treatment of which requires multiple specialties, but there are currently no specialist multidisciplinary treatment centres. Consequently, patients can receive unco-ordinated and ineffective care. Do you agree with calls to establish a multidisciplinary treatment service for evaluation, support and management of patients with chronic and persistent symptoms of tick-borne infections? Minister—maybe you would like to start.

Mairi Gougeon SNP Angus North and Mearns
link

Prior to the pandemic, we had been looking at establishing an infectious diseases managed clinical network. Its aim would be to bring together health practitioners and other professionals who are involved in caring for patients with infectious diseases. Lyme disease would be a workstream within that. I emphasise that that work was in its very early stages prior to the pandemic.

That is very important work that we would seek to continue, because it would bring together everyone who is involved in providing specialist care for particular groups of patients who have complex healthcare needs. The work would include health and other professionals, patients, carers, their families and voluntary groups. Unfortunately, the plans had to be put on hold because of the pandemic, but there is still a strong appetite for developing such a network. The Scottish Government will definitely continue to support that work when public health pressures ease.

Professor Evans
link

I absolutely recognise the frustration that many patients feel about the multiple referrals that they often experience. They see specialist A, then they see specialist B, but they do not feel listened to or that there is a joined-up view of the problems from which they suffer. That is sad; we always want the NHS to be working to the best of its ability, so that situation is clearly not ideal.

The minister has outlined what we hope we can establish—an MCN that includes specialists in infectious diseases all across Scotland to make sure that wherever one lives in Scotland one can get appropriate access to treatment.

I am not involved in making policy in the area, but I do not think that there will be a one-size-fits-all solution. What might work in the central belt will probably not work in the remote and rural areas of Scotland. It will take some looking at. Certainly, bringing together the group of doctors who are most likely to see patients, and formulating ways to ensure that patients are not passed from one referral to another, could be done much more effectively. Dr Hawkins can speak about how the MCN would help.

Dr Hawkins
link

MCNs are used in a number of clinical areas. As Professor Evans said, their aim is to bring together individuals to provide multidisciplinary expertise. It is not just about having an infectious disease physician; there might be rheumatologists, cardiologists and other specialist clinicians in a hospital who have a role in managing Lyme disease. General practitioners and other professionals could help with the support and rehabilitation elements of Lyme management for people who have longer-term symptoms.

We need to make sure that all those who might be involved in the care of people with Lyme disease provide a joined-up service, and that the pathway for the individual is as we want it to be. As Professor Evans said, people should not feel that they are being pushed from pillar to post; there should be a joined-up and holistic approach to their care. An added benefit of the MCN model is that it brings in patients and their families to inform the work of the MCN.

The point that Professor Evans made about there not being a one-size-fits-all service is important. The aim of a network is to offer treatment nearer to the patient and in a way that works for them, rather than their having to travel miles to a central specialist therapist clinic. The view of clinical and other colleagues to whom we are speaking about Lyme disease is that an infectious diseases MCN would be a good way to bring together all the people to reduce the variation that we see in the patient experience in Scotland.

Maurice Corry Con West Scotland
link

That is very interesting. I liked Dr Hawkins’s comment about bringing people together; that is important. The stories that I hear from people who have been affected by the disease show that it manifests itself in different ways; there is the psychological side of it, too. I would hope that some sort of psychological treatment would be included in the multidisciplinary centres. That is very important, because obviously it affects quality of life.

If you would like to respond on the psychological side, that would be very helpful.

Mairi Gougeon SNP Angus North and Mearns
link

The work on developing that was at an early stage and we want to pick that up. Of course, we would consider any possible relevant expertise that should be part of that group.

That point came across strongly when I met Dr Cringean last week. Tom Evans and Gill Hawkins talked about people feeling as though they have been passed from pillar to post, and of course we do not want anyone to experience that or to feel that that is how they are being treated. The infectious diseases MCN will be key in bringing some of that together, and we are keen to progress that piece of work.

David Torrance SNP Kirkcaldy
link

The NICE guidelines acknowledge that chronic infection is not yet researched thoroughly enough to support evidence-based guidance. The NICE guidance that is in place concerns only acute Lyme disease and is based on “poor-quality evidence”, according to Dr Cruikshank. Does the minister share the committee’s concern that this area requires much more research?

Mairi Gougeon SNP Angus North and Mearns
link

Generally, clinicians will—and should—follow evidence-based guidelines such as those that have been produced by NICE. It is probably the case with all diseases that, over time, we build up more evidence and that informs how those diseases are diagnosed and treated. I expect that we will continue to build our evidence base. In previous responses, I talked about the managed clinical network, which will go a long way towards that. There is also the Scottish Lyme disease and tick-borne infections reference laboratory. There are a number of pieces of work that will help develop and build the evidence and research base.

I do not know whether Tom Evans or Gill Hawkins has anything to add to that.

Gail Ross SNP The Deputy Convener · Caithness, Sutherland and Ross
link

Professor Evans, you touched on this in one of your previous answers. Would you like to say anything on this question?

Professor Evans
link

Broadly, I would agree with that. There is certainly room for better quality evidence, particularly for those who are suffering from longer-term symptoms, for whom we do not currently have any particularly good evidence base to offer specific treatments.

Any research requires initiatives from those who are best placed to do it. We have ways of funding research in Scotland, the UK and Europe—people apply for money to do the research and so forth. I would wish to see more of that being done. Obviously, there is an envelope of funding for research in all areas and people have to compete with others who want to research into other conditions.

Some very high-quality work has been done on a very small scale. Colleagues in veterinary medicine do a lot on the survey of wild animal and farmed animal populations, in terms of the range of pathogens that they contain. Good research on where ticks are found is being done by Public Health Scotland and Public Health England. We have a process in which people can send in a tick and it gets identified, which helps us to produce a map. An app is being developed through the University of Aberdeen, in collaboration with the European Space Agency. It will use geospatial locations, and people will be able to put in where they have found a tick and so forth in order to build up a better picture.

I acknowledge that these are small steps, but it is an area in which we would all wish to have better evidence. If there were anything that could be done to support that, I think that that would be a good idea.

David Torrance SNP Kirkcaldy
link

A lack of research and lack of money have been mentioned. Will the Scottish Government do anything to improve the research? Will it increase funding to look into Lyme disease?

Mairi Gougeon SNP Angus North and Mearns
link

The pieces of work that we are looking at in relation to the MCN, and the other on-going work that I mentioned in previous responses, will all help to build the evidence and research base.

Tom Evans talked about competing priorities. Obviously, as we do in other areas, we have to balance this up and look at it, but we want to make progress in this area. We will look at the research and evidence gaps and see what work we can take forward in response. In my opening statement, I talked about the round-table that we will take part in. That will be a good place to talk about the further work that we can do in both the short term and the longer term, whether it is around awareness campaigns or gaps in other areas that we need to focus on.

Tom Mason Con North East Scotland
link

The Scottish Lyme disease and tick-borne infections reference laboratory has ISO accredited testing available for only five strains of Borrelia out of 300. Our evidence shows that cases can be missed based on when tests are taken. Professor Lambert has called for testing for all co-infections to be established and for improved testing for Lyme disease that does not rely on antibody response alone. What is your view on that?

Mairi Gougeon SNP Angus North and Mearns
link

I understand that the petitioners have some concerns about testing. Again, I will bring in my clinical colleagues to give a more substantive answer on this point.

I understand that there are issues around the credibility of some of the other testing that is available. The Scottish Lyme disease and tick-borne infections reference laboratory, which has been referred to in previous responses, does very important work. It gained its reference laboratory status a couple of years ago, and that is important for a number of reasons. First, it means that, as far as possible, testing across Scotland can be standardised; it also ensures that the lab is centrally funded.

At the moment, the laboratory is involved in an Interreg project called NorthTick, on which it is working with seven other countries; that is a three-and-a-half-year project. I think that a specific part of that work is looking to develop a diagnostic test that would allow current infections from Lyme disease to be distinguished from past infection. All of that work will be very important as we go forward.

I am by no means an expert in this area, so I will bring in Tom Evans to see whether he has anything further to add.

10:00

Professor Evans
link

We are fortunate to have an accredited reference laboratory in Scotland; for clinicians, that means that we have a much easier way of accessing tests. Other tests for these infections are offered by the rare and imported pathogens laboratory, which is a division of Public Health England, based down in Porton Down in Salisbury Plain. It is much better that we have that facility in Scotland, particularly because we have a much higher incidence of Lyme disease in Scotland than they do in southern England.

I do not want to get too technical. The tests are based on what the evidence shows us on what the likely infections are, to be sure that we are detecting them. As the petitioners say, there are a range of different species of Lyme disease—the Borrelia bug—and the terminology becomes ever-more confusing, even for me who works in the field. That is something of a nightmare, but the laboratory has well-validated tests to cover the species that are thought to be prevalent in Scotland.

In a NICE study that was done in 2014 of more than 2,000 ticks collected from many different locations across Scotland, 124 ticks were positive for different species of Lyme. Molecular testing was then used to find out the different species. The ones that they found were exactly those for which tests are available, using the antibody tests. I do not think we are missing clinically significant cases of Lyme disease. I should add that the species of Borrelia that are found in Scotland are quite distinct from those in North America and are much more aligned to what we see in Europe. There is a difference there, which is important.

As far as other pathogens go, we have molecular tests for some of the other known tick-borne infections, particularly Anaplasma, which is found in ticks across Europe. We do not have as much information in Scotland and that is maybe something for which we could have a better evidence base, but the disease that it produces is quite distinctive and quite different from Lyme. We are able to diagnose that using molecular testing. I have seen one case of that in Scotland, but the patient actually acquired it on the east coast of America. There is knowledge there but—as Gill Hawkins and the minister said—better understanding and primary knowledge of that would certainly be welcome.

There are some other much more unusual infections. I do not want to get too technical, but Bartonella has been suggested as something found in ticks, but international evidence suggests that that is not something that can be acquired by humans from a tick bite.

I have confidence in what the laboratory is currently doing in Scotland. The clinicians there are always looking at the evidence and adapting their tests and so forth to be sure that they are offering the very best for patients in Scotland. We keep an open mind, and as things develop and we get more evidence I am sure that they will take that on board. Does Gill Hawkins want to add anything?

Dr Hawkins
link

I reinforce what has just been said. The important development in recent years has been the national laboratory’s reference laboratory status, because that brings confidence that the tests that are being used have been validated, that they are the most up-to-date tests available and that they are internationally recognised as the tests that we should be using.

Part of our reference laboratory’s function is to develop its testing and take part in research. As we have heard, the laboratory is actively involved in the NorthTick research project, which is looking at different diagnostic techniques. It is very important that any of those techniques that are taken into the reference laboratory are properly validated and we are sure that they are reliable and are not causing harm by giving false or questionable results.

The reference laboratory status is something that is very important and something that we will obviously build on. As Tom Evans said, as research evidence comes on board, and as more tests are developed, the reference laboratory will be at the forefront of making sure that, where appropriate, those tests are used in Scotland.

The reference laboratory is also working closely in collaboration with experts; in particular, as Tom Evans mentioned, it works with PHE’s rare and imported pathogens laboratory, which has a lot of experience in testing not just for Lyme, but for other tick-borne diseases. That is a very active collaborative relationship, so I think that we can have confidence in that.

David Torrance SNP Kirkcaldy
link

Evidence received by the committee indicates that the majority of GPs lack experience or confidence in providing advice on tick avoidance, managing tick bites or diagnosing and treating Lyme disease. Chronic Lyme patients have been dismissed by infectious diseases consultants, who are unable to help them because of lack of knowledge. What action is being taken to ensure that all healthcare professionals understand the effects of persistent Lyme disease, the insensitivity of the tests for Lyme disease, the importance of adequate early treatment and how to treat chronic Lyme disease?

Mairi Gougeon SNP Angus North and Mearns
link

That point was raised with me when I met Dr Cringean. It is disappointing to hear that people feel that they have been dismissed, or that there is a lack of knowledge or understanding. Gill Hawkins and Tom Evans touched on that in previous responses.

We all know that there is scope for more awareness raising to be done. The Scottish health protection network has done a lot of work in the area on awareness raising, but that does not mean that we are sitting back or that we do not want to do anything else about it. The round-table that we are due to hold will go a long way to establishing the next steps that we will take. In areas in which there has been a high incidence of Lyme disease, GPs might have general awareness, but it cannot just be seen as an issue for one particular area or as a rural issue. There needs to be general awareness of the issue.

We want to encourage people to experience the outdoors and to keep physically active. We have seen a big upsurge in that, especially in the course of the pandemic last year. We want to continue to encourage people to go outdoors, so we need that general awareness all round. Gill Hawkins may have touched on that point earlier. We need a greater increased public awareness of even just the measures that people can take to protect themselves against ticks when they are out and about. We need that awareness in primary care, but we also need that in secondary care so that hopefully it does not occur all that often.

We do not want people feeling like they are being passed from pillar to post, so there are a few different areas of work there where, again, we are not sitting there and not doing anything about it. We recognise more can be done and I see the round-table as an important meeting where we can start to take that work forward.

David Torrance SNP Kirkcaldy
link

Minister, you mentioned the round-table, but GPs are the gatekeepers. If people who are affected by Lyme disease cannot get past that, how do we improve communications with GPs and run an educational programme with them about Lyme disease? Will the Scottish Government run a national campaign when it is the high season for ticks to make the public aware of Lyme disease?

Mairi Gougeon SNP Angus North and Mearns
link

Absolutely. We will be committing resources to support the education and awareness raising around Lyme disease. At the round-table, I want to get the advice and speak to experts and patients to work with us on how best we do that.

David Torrance raises an important point, which I touched on earlier. Again, this is about how we address public awareness. It is also about primary care awareness. A lot of GPs have that awareness. The Scottish health protection network and its tick-borne disease subgroup have been doing a lot of work in that area and are providing educational resources for professionals, as well as trying to engage outdoor organisations. We are keen to take that work forward, which is why we will be committing resource to it and taking that forward later this year.

Maurice Corry Con West Scotland
link

My colleague has raised some of the points that I was going to raise, but I want to dig a bit deeper into public awareness of the disease and tick-borne infections. What can the Scottish Government and the medical profession specifically do to ensure that people know how to recognise and safely remove ticks and what symptoms to look for after the bite?

Mairi Gougeon SNP Angus North and Mearns
link

I am not able to outline the specifics of what any education campaign will consist of at the moment. That is why we want to have the round-table discussion with the people who have suffered this, as well as the clinical experts. We want to get everyone round the table to find out what messages we need to get across and look at the best way that we can do that. It is very important we do that as a first step to make sure that we have that collaboration and that analysis as we try to progress that work. We have committed resource to that and we will do the work, but we want to make sure that we get it right. Holding that round-table meeting and seeking collaboration and advice will be an important step forward.

Professor Evans
link

I echo the views about the need to be sure that we have a more even and better understanding and knowledge for primary and secondary care physicians across Scotland. From the patients whom I see, it is clear that some primary care physicians have a fantastic understanding and knowledge of the disease and treat the patients that they see extremely well, whereas others do not, through no fault of their own; they just do not understand the disease or have not even heard of it particularly. I am sure that there is room for improvement there.

We need to encourage people to go out. If we have learnt anything over the past year, it is the importance of the countryside and enjoying what Scotland has to offer for mental health and wellbeing. That is very important. There are other important public health messages about being in the countryside—not just about ticks—and I think that Gill Hawkins will touch on those.

I live in the middle of Glasgow, but you do not have to go very far to find a tick. Where my dog walks at Mugdock park it is bristling with ticks, so it is not just in the more remote and rural areas that we see the disease, but also in the bigger cities. It is there that clinicians probably have much less experience, because they are not used to seeing it. There is definitely room for improvement. I would echo all the minister’s comments about what we can do moving forward.

Dr Hawkins
link

To build on what has been said, work has been done in the network developing resources and in partnership with the NHS to get information on to the NHS Inform website. There is a specific site there called the outdoor bugs and germs site, which gives advice about Lyme disease, and other infections that people might encounter when they are out and about in the countryside.

The initial work has been done on developing those resources. The next key stage is getting them out there so that people who need to see that information see it before they get to the countryside, so that they come prepared and it becomes part of what they do when they get out and about. You take your sun cream, water and tick remover and you know how to look out for ticks, how to check, what to do if you have a tick bite, how to safely remove the tick, and beyond that, how to look out for symptoms and present to your GP if you feel unwell. We know the messages and we have the materials. It is about how we get that information out there, and I hope that the round-table discussion will help with that. Drawing on the experience and expertise of others to help us to do that will be very important.

Gail Ross SNP The Deputy Convener · Caithness, Sutherland and Ross
link

Thank you. Tom Mason had a question about the minister being willing to engage with the petitioners, but we have heard that she has already done that. Would you like to follow up on that, please?

Tom Mason Con North East Scotland
link

Minister, you kindly outlined that you have engaged with the petitioners, and you have talked about your engagement with research and round-table discussions and so on. What is most important in the whole discussion is how we move forward. Can you confirm your programme for engagement during the next years, months or whatever, and whether that will be sustained? In order to resolve the problem, engagement will have to go on for many years, I guess.

10:15

Mairi Gougeon SNP Angus North and Mearns
link

You are right that it is a complex problem and unfortunately no one solution will solve it. That is why on-going engagement is very important. We want to make sure that any messages that go out—as Gill Hawkins was talking about—go out in the most effective way. Last week, I had a very positive meeting with Dr Cringean, in which we discussed a lot of the issues; it was suggested there that we hold round-table discussions, so that we could bring together all the relevant people and discuss how we move forward.

I do not see that as just a tick-box exercise: the round-table will not be the end of the work. I very much see it as the start of the important process of bringing together all the relevant people. As I said, we have committed resource to running an awareness campaign later in the year. We want to continue that engagement as far as possible, and to make sure that any messages that we put out are put out in the right and most effective way.

Gail Ross SNP The Deputy Convener · Caithness, Sutherland and Ross
link

Thank you. Maurice Corry has a quick supplementary and then I will bring in Alexander Burnett.

Maurice Corry Con West Scotland
link

On 31 October last year, Professor Lambert stated in his submission that the antibody test misses many cases of Lyme disease. He has called for a review of current testing strategies. Do you all agree with that?

Mairi Gougeon SNP Angus North and Mearns
link

When it comes to testing, I am probably better handing over to my clinical colleagues. As we have said, work is being done on that by the Scottish Lyme disease and tick-borne infections reference laboratory.

Professor Evans
link

I echo my previous comments on testing. The reference laboratory follows best international practice on what the evidence base shows are the tests that work and are the most reliable. The tests are constantly under review, as the minister outlined, and we take on board the best possible evidence at the time.

I would not agree with the petitioners that the testing is inadequate in the way that they outline. That is not to say that we will not constantly keep it under review. That is really the key message that I wanted to get across.

Alexander Burnett Con Aberdeenshire West
link

I thank the minister, Dr Hawkins and Professor Evans for coming along today and answering questions. It is very important, particularly for petitioners, that while the pandemic goes on, other subjects are not being ignored, particularly this one, which has been going on for some time.

I also thank the minister for meeting with Dr Cringean. I do not know whether she met with both petitioners. Correct me if I am wrong, but I believe the other petitioner is one of her constituents and certainly—as is well-publicised—caught Lyme in her constituency, not up on the high ground, but down on the coast. It shows that the disease can be caught anywhere across Scotland.

I have two questions and one point that you might want to come back on. The first question is really one of process, following on what Tom Mason was saying, and thanking the minister for holding the round-table. What format will the round-table sessions take? I suggest that the subject is broken down into Professor Lambert’s six areas, so that we can have proper and detailed dialogue on each part.

What will come out of the round-table discussions, and what is the process for something coming out of them? We have had so many talking shops and discussions, but it is never clear, especially to the petitioners, what process is expected to result from a round-table. Perhaps the minister could set out how the round-table will feed into future deliberations and policy, and how she will respond to that round-table. That is my first question.

Gail Ross SNP The Deputy Convener · Caithness, Sutherland and Ross
link

Can you ask both questions together in the interests of time, please?

Alexander Burnett Con Aberdeenshire West
link

Certainly. My second one is a point and a bit of criticism, I am afraid. Dr Hawkins has talked a lot about raising awareness and the minister has mentioned raising awareness multiple times. I think the petitioners and other people with Lyme are probably quite sick of hearing that that is what will happen, because we have been hearing about raising awareness for years now and it is simply not substantiated by the evidence of Government performance, or of publication and awareness, particularly since, as the minister pointed out, we are encouraging more people to exercise outdoors. You might like to come back on that point.

The third point, which is a question—my final point, deputy convener—is again about how we move forward. One of the main criticisms has been about the lack of patient representation. That is well documented in the evidence given. How will that patient representation materialise? At the moment we are having to come forward with a petition and I do not know what will happen to the petition after today. It is very much a cry for help from those who have Lyme and feel that they lack a voice. In the interests of keeping the issue live after the petition, can the minister confirm how patient representation will happen?

Gail Ross SNP The Deputy Convener · Caithness, Sutherland and Ross
link

Thank you. Minister, there were three points for you there.

Mairi Gougeon SNP Angus North and Mearns
link

I think that I have a note of them all, so I will try to cover them.

I see patient representation and the lack of a voice as absolutely critical, not just in the area of Lyme disease, but in all other aspects of my portfolio. One thing that I am keen to do is to engage with people. I want to hear about people’s experience and to hear that from them directly. That is why I was keen to meet the petitioner last week. Alexander Burnett asked whether I was able to meet both petitioners, but unfortunately I was not. I met Dr Cringean but, because of the timing of the meeting, I do not think that everyone could attend. I see engagement as a key element of my role; I want to engage, which is why I see the round-table having an important role.

I hope that members will understand that the meeting was just last week and I am appearing before the committee today. I cannot as yet give you the detail of the arrangements and format of the round-table, because it has not been established. It will, however, be key, because it brings forward that patient voice. The petitioners will be there, and we will have the clinical expertise there. That is where we want to tease out a lot of the issues. We are all going into it open-minded and not prejudging. I genuinely want to hear about people’s experience, about what we can do about the messaging, and how we can make sure that messaging is effective.

I cannot be any clearer than what I have already said today. We have committed resource to it and we will be doing that public awareness raising. I have given that commitment today and I assure the committee that it will happen, but we want to inform that as much as possible and that is where this work is very important.

I understand that the petitioners might be concerned that it looks like there has been a lot of talking and not a lot of action. I am fairly new in this post and I can only do what I can do. I have set out what I am going to do and I will be happy to keep the committee updated on that work.

Gail Ross SNP The Deputy Convener · Caithness, Sutherland and Ross
link

Does Alexander Burnett want to come back in very briefly?

Alexander Burnett Con Aberdeenshire West
link

Very briefly. On that final point, I was talking not so much about meeting the minister, which we are very grateful for, as about patient representation on the actual body mentioned within the evidence. The name escapes me for a second, but there is a specific body that does not have a patient representative from Scotland. Could the minister address that specifically? That is my final point.

Mairi Gougeon SNP Angus North and Mearns
link

I do not know whether that refers to a point that was given in previous evidence. I think that my predecessor wrote to the committee with further information on that towards the end of October. I want to make sure that we have patient representation and involvement. Of course, there are some groups in some areas where that is not always going to be appropriate. Where there are clinical discussions or clinical conversation, I think there is an appropriate place for that, but not necessarily in some of the groups that we might have talked about today. If the member wants to write to me with more specific details on that, I would be more than happy to look into it and get back to him.

Gail Ross SNP The Deputy Convener · Caithness, Sutherland and Ross
link

Thank you, minister. That is the end of our evidence session. I thank the minister, Professor Evans and Dr Hawkins for their thorough evidence.

We must decide what we will do with the petition. As Alexander Burnett has already suggested, it would be very difficult for us to close the petition at this stage, given that there are so many outstanding issues. The Scottish Government has committed to quite a lot of actions that we probably need to keep an eye on, so I suggest that we continue the petition and put it in our legacy paper for the committee that will come after us, along with a suggestion to seek assurances and updates from the Scottish Government to address any issues that have been brought up during this session. I will quickly go to members for their opinions.

Alexander Burnett Con Aberdeenshire West
link

I agree. I wish to continue the petition. Too many doors are still open and questions are still to be answered. It is important that we see the actions that the Scottish Government has said it will deliver. Therefore, I request that we continue the petition. Obviously, it will be one for the legacy paper; I agree entirely, deputy convener, on that.

Tom Mason Con North East Scotland
link

Yes, I agree with what has been said so far. There will be a change of Government, so the legacy paper will carry over the issues and they can be followed up in future. I expect the issue still to be on the cards for at least five years before anything is really resolved on an on-going basis that does not need detailed scrutiny.

David Torrance SNP Kirkcaldy
link

I agree with the deputy convener and my colleagues that we should keep the petition open and take it forward, just to see what progress has been made by the Scottish Government.

Gail Ross SNP The Deputy Convener · Caithness, Sutherland and Ross
link

Thank you. Alexander Burnett, would you like to come in?

Alexander Burnett Con Aberdeenshire West
link

Thank you very much, deputy convener, and I thank you and your committee for that decision. I think that it will be greatly appreciated by the petitioners. It is very much still a live subject, so that is much welcomed. As this will probably be the final time that I appear in front of you regarding Lyme disease in this session of Parliament, I thank you and your committee for your time and interest and for keeping the petition alive on behalf of myself and the petitioners.

Gail Ross SNP The Deputy Convener · Caithness, Sutherland and Ross
link

We thank you for coming along. Your input has been very important. We thank the petitioners as well.

Based on our discussion, we will continue the petition and include it in the legacy paper for the successor committee, along with the suggestion to seek an update from the Scottish Government on any progress made to address the issues raised during the evidence session.

Are we agreed on that course of action? We are.

I suspend the meeting to allow our other witnesses and the convener to rejoin us. Again, I thank all our witnesses.

10:28 Meeting suspended.

10:35 On resuming—

  1. 09:30 Decision on Taking Business in Private Procedure · 1
  2. 09:30 Continued Petitions Petitions · 58
  3. 10:15 Continued Petitions Petitions · 91

The type of each item (debate, statement, questions, members’ business and so on) and the times shown are worked out by this site from headings, the chair’s opening words and the Official Report’s running timestamps. They are not the Parliament’s own classification. Text: the Scottish Parliament Official Report.